(Q34381296)

1 August 2017

title

Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting (English)

1 reference

1 August 2017

1 reference

Marta Duran

1

1 reference

1 August 2017

Eulàlia Pérez

2

1 reference

1 August 2017

Sergio Abanades

3

1 reference

1 August 2017

Xavier Vidal

4

1 reference

1 August 2017

Cristina Saura

5

1 reference

1 August 2017

Margarita Majem

6

1 reference

1 August 2017

Edurne Arriola

7

1 reference

1 August 2017

Manel Rabanal

8

1 reference

1 August 2017

Antoni Pastor

9

1 reference

1 August 2017

Magí Farré

10

1 reference

1 August 2017

Neus Rams

11

1 reference

1 August 2017

Joan-Ramon Laporte

12

1 reference

1 August 2017

Dolors Capellà

13

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

British Journal of Clinical Pharmacology

1 August 2017

published in

1 reference

1 August 2017

volume

70

1 reference

1 August 2017

issue

5

1 reference

1 August 2017

page(s)

656-663

1 reference

The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997305

Endocannabinoids and the gastrointestinal tract: what are the key questions?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997305

Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting: beyond prevention of acute emesis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997305

Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997305

Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997305

Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997305

Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997305

American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997305

Plant, synthetic, and endogenous cannabinoids in medicine

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997305

Identification and functional characterization of brainstem cannabinoid CB2 receptors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997305

Pharmacokinetics and pharmacodynamics of cannabinoids

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997305

A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997305

Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997305

Cannabinoids in humans. I. Analysis of delta 9-tetrahydrocannabinol and six metabolites in plasma and urine using GC-MS.

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2010.03743.X

Assessing the impact of chemotherapy-induced nausea and vomiting on patients' daily lives: a modified version of the Functional Living Index-Emesis (FLIE) with 5-day recall

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997305

Cannabidiol, a non-psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997305

GW-1000. GW Pharmaceuticals

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21039759

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[Therapeutic use of cannabis: results of a prospective survey in Catalonia (Spain)]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21039759

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.2010.03743.X

1 reference

1 August 2017

1 reference

1 August 2017

1 reference